James A. Schoeneck, President and CEO at DEPOMED INC (DEPO), sold 36,727 shares at $15.85 ($582K) on 2014-12-02, disclosed to the SEC on 2014-12-03.
Scheduled sale ($582k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FGEN | BUY | 2025-03-24 | $105K | — | Filing → |
| FGEN | SELL | 2023-06-09 | $256K | — | Filing → |
| FGEN | SELL | 2019-05-09 | $94K | — | Filing → |